Biogen CMO joins Flex Pharma's SAB
This article was originally published in Scrip
Executive Summary
Flex Pharma, a biotechnology company developing innovative treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions, has named Dr Alfred Sandrock Jr, current chief medical officer of Biogen, to its scientific advisory board. Dr Sandrock Jr is Biogen's group senior vice-president of development sciences and CMO. But since joining Biogen in 1998, he has held several senior executive positions, including senior vice-president of development sciences, senior vice-president of neurology R&D, and vice-president of clinical development, neurology.